跳至主要内容
临床试验/ISRCTN16013232
ISRCTN16013232进行中(未招募)未知

Can mandibular advancement device treatment for obstructive sleep apnoea reduce nocturnal gastro-oesophageal reflux: a feasibility study

Guy's and St Thomas' NHS Foundation Trust0 个研究点目标入组 44 人开始时间: 2022年10月13日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
44

研究概览

简要总结

2023 Protocol article in https://doi.org/10.1136/bmjopen-2023-076661 (added 25/08/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adult patients aged 18 years old and over
  • 2. Confirmed OSA with Apnoea-Hypopnoea Index (AHI) score between 10 and 30
  • 3. Confirmed gastro-oesophageal reflux disease with greater than 6 percent of acid exposure time < pH 4 over 24 hours
  • 4. Patient will not have previously had CPAP or MAD therapy
  • 5. Sufficient healthy teeth to support a mandibular advancement device (10 teeth in each jaw, no periodontal pockets > 5, no frank cavitation or loose crowns/bridges)
  • 6. Willing and able to provide informed consent to the study

排除标准

  • 1. Pregnancy or breast feeding
  • 2. Unable or unwilling to stop GORD medication 2 days prior to assessment or unable to undergo manometry and pH impedence testing
  • 3. Known liver disease or oesophageal/gastric varices
  • 4. Previous surgery or intervention for reflux such as fundoplication
  • 5. Any previous treatment for oesophageal neoplasia.
  • 6. Unable/unwilling to tolerate either a CPAP mask or a mandibular advancement device
  • 7. Medical history likely to impact on attendance or 24-hour impedance testing
  • 8. Participation in other research within previous 30 days

研究者

相似试验